Gallardon, France

Gerard Cousin

This inventor holds 4 USPTO granted patents, plus 2 CIPO patents. Top assignees: Laboratoires Prographarm, Laboratories Prographarm, Prographarm Laboratories. Active years: 1993-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard Cousin. Retrieved from https://idiyas.com/inventor/gerard-cousin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 407(Granted Patents)


Location History:

  • Gallardon, FR (1993 - 1999)
  • Le Mesnil Ponceau, FR (2000)

Company Filing History:


Years Active: 1993-2000

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gerard Cousin: Innovator in Multiparticulate Pharmaceutical Forms

Introduction

Gerard Cousin is a notable inventor based in Gallardon, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of multiparticulate pharmaceutical forms. With a total of 4 patents to his name, Cousin's work focuses on enhancing the delivery and effectiveness of active ingredients in medications.

Latest Patents

Cousin's latest patents include a multiparticulate pharmaceutical form with programmed and pulsed release. This innovative invention allows for the active ingredient to become available within 4 to 8 hours after ingestion, followed by a gradual release over the next 8 to 20 hours. The formulation is unique as it is free of organic acids and consists of medicinal spheroids with a neutral spherical core. The core is coated with a mixture of hydrosoluble and non-hydrosoluble polymers, ensuring uniform distribution of the active ingredient. Additionally, the second coating comprises pH-independent polymers with varying permeability rates, enhancing the drug's effectiveness in different gastrointestinal environments.

Another significant patent involves a preparation process for a multiparticulate pharmaceutical form that allows for controlled release of active ingredients. This process enables sufficient concentrations of one or more active ingredients to be administered in one or two doses over a 24-hour period, improving patient compliance and therapeutic outcomes.

Career Highlights

Throughout his career, Gerard Cousin has worked with reputable companies such as Laboratoires Prographarm and Prographarm Laboratories. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and product development.

Collaborations

Cousin has collaborated with notable colleagues, including Edouard Gendrot and Etienne Bruna. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical technologies.

Conclusion

Gerard Cousin's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving medication delivery systems. His work continues to influence the industry and enhance patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…